NL7909199A - Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. - Google Patents

Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. Download PDF

Info

Publication number
NL7909199A
NL7909199A NL7909199A NL7909199A NL7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A
Authority
NL
Netherlands
Prior art keywords
thiazolidine
carboxylic acid
pharmaceutically acceptable
acceptable salt
agent
Prior art date
Application number
NL7909199A
Other languages
English (en)
Dutch (nl)
Original Assignee
Gosalvez Mario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gosalvez Mario filed Critical Gosalvez Mario
Publication of NL7909199A publication Critical patent/NL7909199A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
NL7909199A 1978-12-21 1979-12-20 Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. NL7909199A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/971,729 US4384001A (en) 1978-12-21 1978-12-21 Treatment of tumors with thiazolidine-4-carboxylic acid
US97172978 1978-12-21

Publications (1)

Publication Number Publication Date
NL7909199A true NL7909199A (nl) 1980-06-24

Family

ID=25518727

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7909199A NL7909199A (nl) 1978-12-21 1979-12-20 Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan.

Country Status (16)

Country Link
US (1) US4384001A (fr)
JP (1) JPS55115822A (fr)
AU (1) AU5390579A (fr)
BE (1) BE880744A (fr)
CA (1) CA1149284A (fr)
DE (1) DE2951050A1 (fr)
DK (1) DK542979A (fr)
ES (1) ES487052A0 (fr)
FR (1) FR2444459A1 (fr)
GB (1) GB2039736B (fr)
IL (1) IL58948A0 (fr)
IT (1) IT1193348B (fr)
LU (1) LU82013A1 (fr)
NL (1) NL7909199A (fr)
SE (1) SE7910300L (fr)
ZA (1) ZA796918B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS57128625A (en) * 1981-01-30 1982-08-10 Rikagaku Kenkyusho Carcinostatic
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
FR2547728B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide d thiazolidine carboxylique
FR2547729B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide dl thiazolidine carboxylique
JPS62501769A (ja) * 1984-12-18 1987-07-16 デイビツト　ラビン 細胞毒性アルデヒドとベニシラミンとの反応性成物を含有する抗腫瘍組成物及びその使用方法
JPH066578B2 (ja) * 1985-12-27 1994-01-26 三共株式会社 チアゾリジン誘導体
JPH01170063U (fr) * 1988-05-11 1989-11-30
JPH0467539U (fr) * 1990-10-18 1992-06-16
DE69214467T3 (de) * 1991-01-10 2000-09-28 Transcend Therapeutics Inc Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
ES2277787B1 (es) * 2006-01-02 2008-06-16 Universidad De Cadiz Empleo de tioprolina en tratamientos de reduccion de peso corporal.

Also Published As

Publication number Publication date
FR2444459B1 (fr) 1983-04-01
BE880744A (fr) 1980-06-19
FR2444459A1 (fr) 1980-07-18
SE7910300L (sv) 1980-06-22
GB2039736B (en) 1983-04-13
AU5390579A (en) 1980-06-26
DE2951050A1 (de) 1980-07-10
IL58948A0 (en) 1980-03-31
IT1193348B (it) 1988-06-15
CA1149284A (fr) 1983-07-05
US4384001A (en) 1983-05-17
ZA796918B (en) 1980-11-26
ES8102108A1 (es) 1980-12-16
IT7928170A0 (it) 1979-12-18
ES487052A0 (es) 1980-12-16
JPS55115822A (en) 1980-09-06
JPS6328045B2 (fr) 1988-06-07
DK542979A (da) 1980-06-22
GB2039736A (en) 1980-08-20
LU82013A1 (fr) 1981-02-03

Similar Documents

Publication Publication Date Title
SK137996A3 (en) Cancer treatment and metastasis prevention
NL7909199A (nl) Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan.
US6407125B1 (en) Pharmacological agent and method of treatment
US6579891B1 (en) Agent and method for prevention and treatment of cancer in animals
US20060074063A1 (en) Pharmacological agent and method of treatment
CN111346081B (zh) 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途
US6403618B1 (en) Agent and method for controlling angiogenesis
CN115463118A (zh) 和厚朴酚在制备治疗或预防毛细血管瘤的药物中的用途
CN108685892B (zh) 绿原酸及其组合物在制备治疗鳞状细胞癌的药物中的用途
AU709620B2 (en) New applications of lysozyme dimer
Taliaferro The Role of the Spleen and the Lymphoid-macrophage System in the Quinine Treatment of Gallinaceum Malaria: I. Acquired Immunity and Phagocytosis
JPS6379824A (ja) 制癌剤
US6441009B1 (en) Agent and method of preventing and treating heavy metal exposure and toxicity
KR20060038387A (ko) 화학요법을 받고 있는 암 환자를 치료하는 방법
Boughattas et al. Modulation of cisplatin chronotoxicity related to reduced glutathione in mice
CN111514290A (zh) 一种葫芦素组合物及其用途
CN113456643B (zh) 一种含普那布林的药物组合及其应用
WO2023204380A1 (fr) Support de substance physiologiquement active
RU2426531C1 (ru) Жидкая водная фармацевтическая композиция амброксола и фармацевтический препарат на ее основе, предназначенные для лечения заболеваний дыхательных путей с образованием вязкой мокроты (варианты)
RU2282437C1 (ru) Средство для лечения болезней суставов
RU2681546C1 (ru) Способ экстренной профилактики клещевого вирусного энцефалита
US20130079416A1 (en) Homeopathic medicament comprising phenacetin for the treatment of cancer
RU2119334C1 (ru) Антгельминтное средство
US20060240117A1 (en) Snake powder extract for treatment of cancer
CN115737817A (zh) 络氨酸激酶抑制剂在制备治疗棘球蚴病药物中的应用

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed